BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intevac, Inc. (Nasdaq – IVAC), Paragon 28, Inc. (NYSE – FNA), Logility Supply Chain Solutions, Inc. (Nasdaq – LGTY), Enfusion, Inc. (NYSE – ENFN)

/EIN News/ -- BALA CYNWYD, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Intevac, Inc. (Nasdaq – IVAC)

Under the terms of the Merger Agreement, Intevac will be acquired by Seagate Technology Holdings plc (“Seagate”) (Nasdaq – STX) for $4.00 per share in cash for each Intevac share. In connection with the closing of the Transaction, Intevac will pay a one-time special dividend of $0.052 per share. The investigation concerns whether the Intevac Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.

Additional information can be found at https://www.brodskysmith.com/cases/intevac-inc-nasdaq-ivac/

Paragon 28, Inc. (NYSE – FNA)

Under the terms of the agreement, Paragon 28 will be acquired by Zimmer Biomet Holdings, Inc. (NYSE and SIX – ZBH) for an upfront payment of $13.00 per share in cash, corresponding to an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. Paragon 28 shareholders will also receive a non-tradeable contingent value right (CVR) entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved. The investigation concerns whether the Paragon 28 Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.

Additional information can be found at https://www.brodskysmith.com/cases/paragon-28-inc-nyse-fna/.

Enfusion, Inc. (NYSE – ENFN)

Under the terms of the agreement, Enfusion will be acquired by Clearwater Analytics (“Clearwater”) (NYSE – CWAN) for $11.25 per share in cash in a deal worth approximately $1.5 billion. The investigation concerns whether the Enfusion Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.

Additional information can be found at https://www.brodskysmith.com/cases/enfusion-inc-nyse-enfn/.

Logility Supply Chain Solutions, Inc. (Nasdaq – LGTY)

Under the terms of the agreement, Logility will be acquired by Aptean for $14.30 per share in cash. The investigation concerns whether the Logility Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.

Additional information can be found at https://www.brodskysmith.com/cases/logility-supply-chain-solutions-inc-nasdaq-lgty/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.